Circularis

Control any gene, any species

Circularis operates in biopharma based in United States, founded in 2014.

Profile

Circularis has developed a powerful and novel method to regulate gene expression to increase minimum bio-therapeutic production yields by up to ten times. We can do this for any gene in any species with no prior knowledge of the regulatory elements or coding sequence. Circularis is the only company that can deliver optimized gene expression and increased production yields for any protein from any species.

As a business in biopharma, Circularis is listed here with the public details available about it.

The company is recorded as being based in United States.

The company is listed at the SOSV portfolio company stage of development.

Website: circularisbiotech.com